NIHSIN-PA
7215PA
NEXGRAM
0096
XOX
0165
TALAMT
2259
GPACKET
0082
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||
Cash from operating activities | 19.36M | 4.18M | 8.44M | 252.46%17.81M | -291.86%-11.68M | 6.09M |
Net profit before non-cash adjustment | --7.04M | --8.76M | --5.11M | 262.86%26.18M | 15.81%7.22M | --6.23M |
Total adjustment of non-cash items | --1.54M | --682K | --1.61M | 35.93%8.7M | 86.87%6.4M | --3.43M |
-Depreciation and amortization | --884K | --922K | --820K | 5.61%3.79M | 0.59%3.58M | --3.56M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | --0 | 859.65%1.09M | 103.97%114K | ---2.87M |
-Disposal profit | ---- | ---- | ---- | --0 | --0 | ---12K |
-Net exchange gains and losses | ---- | ---- | ---- | --0 | -2.47%79K | --81K |
-Other non-cash items | --226K | ---240K | --794K | 45.64%3.82M | -1.54%2.63M | --2.67M |
Changes in working capital | --10.78M | ---5.27M | --1.72M | 32.54%-17.07M | -609.51%-25.3M | ---3.57M |
-Change in receivables | --9.48M | --963K | ---3.91M | -310.32%-8.71M | 93.61%-2.12M | ---33.22M |
-Change in inventory | --1.85M | ---7.08M | ---1.39M | 159.96%4.44M | -219.05%-7.41M | --6.22M |
-Change in payables | ---542K | --854K | --7.01M | 18.86%-12.8M | -167.30%-15.77M | --23.44M |
Dividends paid (cash flow from operating activities) | ||||||
Dividends received (cash flow from operating activities) | ||||||
Interest paid (cash flow from operating activities) | ||||||
Interest received (cash flow from operating activities) | ||||||
Tax refund paid | -1.52M | -1.13M | -2.26M | -679.25%-1.88M | -270.77%-241K | -65K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | --17.84M | --3.05M | --6.19M | 233.63%15.94M | -297.93%-11.93M | --6.03M |
Investing cash flow | ||||||
Net PPE purchase and sale | ---17.57M | ---12.73M | ---1.5M | -888.68%-3.14M | 53.64%-318K | ---686K |
Net investment product transactions | ---- | ---- | --61.66M | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | 157.99%2.65M | 151.17%1.03M | ---2.01M |
Interest received (cash flow from investment activities) | --627K | --840K | --201K | -16.59%347K | -19.69%416K | --518K |
Net changes in other investments | --5.73M | ---- | ---- | ---- | ---- | ---- |
Investing cash flow | ---11.21M | ---113.75M | --60.36M | -113.35%-150K | 151.73%1.12M | ---2.17M |
Financing cash flow | ||||||
Net issuance payments of debt | --8.26M | ---14.11M | ---21.05M | -94.36%1.97M | 282.75%34.96M | --9.13M |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | ---120K | ---57K | ---14K | -41.46%-174K | 8.21%-123K | ---134K |
Issuance fees | --0 | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | ---3.98M | ---- | ---- | ---- | ---2.38M | ---- |
Interest paid (cash flow from financing activities) | ---853K | ---600K | ---995K | -37.13%-4.17M | 4.49%-3.04M | ---3.18M |
Net other fund-raising expenses | ---- | ---- | ---60.15M | 180.58%3.62M | -35.86%-4.49M | ---3.3M |
Financing cash flow | --3.31M | --98.01M | ---82.21M | -95.01%1.24M | 891.80%24.92M | --2.51M |
Net cash flow | ||||||
Beginning cash position | --14.47M | --27.16M | --42.82M | 347.43%18.19M | 276.89%4.07M | ---2.3M |
Current changes in cash | --9.95M | ---12.69M | ---15.66M | 20.58%17.03M | 121.89%14.12M | --6.37M |
Effect of exchange rate changes | ---- | ---- | ---- | --0 | --0 | ---2K |
End cash Position | --24.42M | --14.47M | --27.16M | 93.63%35.22M | 347.43%18.19M | --4.07M |
Free cash flow | --278K | ---9.69M | --4.69M | 202.11%12.79M | -338.20%-12.53M | --5.26M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.